Clinical trials
Muscular Atrophy, Spinal trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 5 |
| National Taiwan University Hospital | 4 |
| Istanbul Medipol University Hospital | 2 |
| AbiliTech Medical Inc. | 1 |
| Ain Shams University | 1 |
| All India Institute of Medical Sciences | 1 |
| Bahçeşehir University | 1 |
| Bar-Chama, Natan, M.D. | 1 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Clinic for Special Children | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy, Spinal | 35 |
| Muscular Dystrophies | 3 |
| Spinal Muscular Atrophies of Childhood | 3 |
| Motor Neuron Disease | 2 |
| Muscular Diseases | 2 |
| Muscular Dystrophy, Duchenne | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Bulbar Palsy, Progressive | 1 |
| Cerebral Palsy | 1 |
| Colonic Neoplasms | 1 |
Trials
Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.